Paydirt
TW
Insider

Todd Watanabe

See Remarks · Arcutis Biotherapeutics

Todd Watanabe (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.5M of ARQT (48,945 sh × $30.36, as filed), executed Nov 24 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4

Median ADV $51.3M across their filed names

Open performance→
Volume by month
$1.9M$943K$0Dec 2024Jun 2025Dec 2025Jun 2026Aug 2025 · sells $165KSep 2025 · sells $169KOct 2025 · sells $1.9MNov 2025 · sells $1.8MFeb 2026 · sells $506KMar 2026 · sells $913KAug 2026 · sells $114KNov 2026 · sells $139K
Buys $0 Sells $5.7M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names
ARQT Arcutis Biotherapeutics, Inc. ARQT · 0 buys · 10 sells 10 filings
Recent filings
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $169K
9,625 sh × $17.54
Exec Sep 8 2025
Filed Sep 10 2025 · 5:30 PM ET
ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $165K
11,547 sh × $14.33
Exec Aug 4 2025
Filed Aug 5 2025 · 5:30 PM ET